Business
First-In-Human Study of Accommodating Intraocular Lens Set to Begin June 26, 2025
(TheNewswire) Calgary, Alberta – TheNewswire - June 24, 2025 - Ocumetics...

About this update from Ocumetics Technology Corp
[{"type":"text","content":"First-In-Human Study of Accommodating Intraocular Lens Set to Begin June 26, 2025\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, Alberta –\n \n\n TheNewswire -\n \n\n June 24, 2025\n \n\n -\nOcumetics Technology Corp\n \n\n .\n \n\n (“Ocumetics” or the “Company”)\n(TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced\nophthalmic technology, is pleased to confirm\n \n\n the\nculmination of nearly two decades of research and development as it\nprepares for first-in-human (FIH) clinical studies of its\nrevolutionary accommodating intraocular lens (the “Ocumetics\nLens”).\n \n\n\n\n “This moment is nothing short of transformational,”\nsaid Dean Burns, CEO of Ocumetics.  “With clinical study site\ninitiation set to begin this week, we are now taking the most\nsignificant step yet in bringing the Ocumetics Lens to market.  What\nbegan as a dream to restore the youthful eye’s natural ability to\nfocus distant and near objects after cataract surgery is one step\ncloser to becoming a reality.  With a world class team, innovative\ntechnology, and unwavering determination, we are redefining what’s\npossible in ophthalmology.”\n \n\n\n\n This summer marks a groundbreaking leap into the future\nof vision correction for Ocumetics as it initiates pivotal clinical\ntrials of its accommodating intraocular lens – an implantable device\nthat promises to provide patients worldwide with youthful, dynamic\nvision after cataract surgery.\n \n\n\n\n The Company has made impressive strides leading to this\npivotal moment:\n \n\n\n\n\n\n Lens Design Freeze:  Final lens specifications are\nlocked in, marking a major milestone in the journey from design and\ndevelopment to commercialization.\n \n\n\n\n\n\n\n\n Manufacturing Completed: Ocumetics successfully\nproduced its first batch of lenses to be used for the upcoming FIH\nimplantations.\n \n\n\n\n\n\n Laboratory Testing:  Laboratory bench testing\nconfirmed that the Ocumetics Lens provides sufficient accommodative\npower to restore a patient’s ability to focus both distance and near\nobjects without glasses.\n \n\n\n\n\n\n Mexico City Selected as Trial Site: Following an\nextensive review of available options, Mexico City was chosen...